A Phase 2, Multi-Center, Open-label, Randomized, Paralle

Project: Research project

Project Details

Description

A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Group Study of A Lenalidomide (Revlimid??) Regimen or A Sequential Azacitidine (Vidaza??) plus Lenalidomide (Revlimid??) Regimen versus Leukemia (CC-5013-AML-001)
StatusFinished
Effective start/end date10/17/1212/31/17

Funding

  • Celgene Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.